NEW YORK (GenomeWeb News) – Idaho Technology and Life Technologies' Applied Biosystems business have entered into a cross-licensing pact covering instrument, software, and reagents, Idaho Technology said today.
The licensing deal includes patents that relate to real-time polymerase chain reaction methods and instrumentation, including the 5' nuclease process SYBR Green I in PCR reactions. More specific details and financial terms of the agreement were not disclosed.
The cross-licensing pact "enables innovation in a more open environment that is good for business and ultimately benefits customers," Randy Rasmussen, president of Idaho Technology, said in a statement.
Salt Lake City-based Idaho Technology is privately held and licensed the rapid PCR technology from the University of Utah. It created the LightCycler PCR-based instrument, which it sublicensed to Roche Diagnostics.